Hemochromatosis: genes and variants
Explore variant evidence for Hemochromatosis across 2 analyzed proteins (SLC40A1, HFE). Linked ClinVar records include 42 pathogenic or likely pathogenic variants, 69 variants of uncertain significance and 19 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hemochromatosis
SLC40A1: Ferroportin
It exports iron from enterocytes, macrophages, and hepatocytes into the circulation and is directly inhibited by hepcidin. Pathogenic variants cause ferroportin disease or hepcidin-resistant iron overload, depending on whether they impair export or hepcidin regulation.
37 ClinVar pathogenic / likely pathogenic and 69 uncertain variants in SLC40A1 have source records linked to Hemochromatosis. Association strength is not clinical gene validity.
HFE: Hereditary hemochromatosis protein
It helps the liver sense circulating iron availability and regulate hepcidin, thereby controlling intestinal iron absorption and systemic iron distribution. The C282Y variant is the major genetic cause of HFE-related hereditary hemochromatosis and progressive iron overload.
5 ClinVar pathogenic / likely pathogenic and 19 uncertain variants in HFE have source records linked to Hemochromatosis. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Hemochromatosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC40A1 G80S | 80 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 R88G | 88 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 N144D | 144 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 G204S | 204 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 C326Y | 326 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 R88T | 88 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 D157G | 157 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 R178Q | 178 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC40A1 G490D | 490 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| HFE L183P | 183 | Alpha-2 | Pathogenic / likely pathogenic (★★) |
| SLC40A1 S209L | 209 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| HFE Q283P | 283 | Ig-like C1-type | Pathogenic / likely pathogenic (★★) |
| SLC40A1 C326F | 326 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 N144Y | 144 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 N144H | 144 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 W158C | 158 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 G490S | 490 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 S71F | 71 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 N185T | 185 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC40A1 L233P | 233 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC40A1 G267D | 267 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC40A1 D181V | 181 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 G80V | 80 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 D181N | 181 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 Q182H | 182 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 G204V | 204 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 G323D | 323 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 G323V | 323 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 Q182E | 182 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 A77D | 77 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 V160A | 160 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 G206R | 206 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 R179T | 179 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 V63A | 63 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 Y227D | 227 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 A350D | 350 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 V531A | 531 | Transmembrane | Pathogenic / likely pathogenic |
| HFE S65C | 65 | Alpha-1 | Pathogenic / likely pathogenic |
| HFE S88C | 88 | Alpha-1 | Pathogenic / likely pathogenic |
| HFE R330M | 330 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 T148A | 148 | Transmembrane | Pathogenic / likely pathogenic |
| SLC40A1 Y501C | 501 | Transmembrane | Pathogenic / likely pathogenic |
Which prediction tools work for Hemochromatosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 98 out of 100
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 85 out of 100
- CADD: 85 out of 100
- phyloP: 82 out of 100
- SpliceAI: 38 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 33 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Hemochromatosis
- Alzheimer disease, also linked to HFE
- Microvascular complications of diabetes, also linked to HFE
- Hereditary hemochromatosis, also linked to HFE
Frequently asked questions
Which genes have records linked to Hemochromatosis?
This view contains 2 analyzed proteins: SLC40A1, HFE. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 42 pathogenic or likely pathogenic variants, 69 variants of uncertain significance and 19 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 163 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center